Reflective of broader investment concerns around Healius, a single investor has sold a A$74m (US$50.2m) block of shares in the Australian healthcare company. This equates to a 4% share in the…
Reflective of broader investment concerns around Healius, a single investor has sold a A$74m (US$50.2m) block of shares in the Australian healthcare company. This equates to a 4% share in the…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference